Cargando…
The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial
BACKGROUND: Curing locally advanced gastric cancer through surgery alone is difficult. Adjuvant and neoadjuvant chemotherapy bring potential benefits to more patients with gastric cancer based on several clinical trials. According to phase II studies and guidelines, SOX regimen as neoadjuvant chemot...
Autores principales: | Wang, Xinxin, Li, Shuo, Sun, Yihong, Li, Kai, Shen, Xian, Xue, Yingwei, Liang, Pin, Li, Guoli, Chen, Luchuan, Zhao, Qun, Li, Guoxin, Fu, Weihua, Liang, Han, Xin, Hairong, Suo, Jian, Fang, Xuedong, Zheng, Zhichao, Xu, Zekuan, Chen, Huanqiu, Zhou, Yanbing, He, Yulong, Huang, Hua, Zhu, Linghua, Yang, Kun, Ji, Jiafu, Ye, Yingjiang, Zhang, Zhongtao, Li, Fei, Wang, Xin, Tian, Yantao, Park, Sungsoo, Chen, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786891/ https://www.ncbi.nlm.nih.gov/pubmed/33402102 http://dx.doi.org/10.1186/s12885-020-07764-7 |
Ejemplares similares
-
Postoperative chemotherapy with S-1 plus oxaliplatin versus S-1 alone in locally advanced gastric cancer (RESCUE-GC study): a protocol for a phase III randomized controlled trial
por: Hu, Xiang, et al.
Publicado: (2017) -
In-Hospital Mortality Risk Model of Gastric Cancer Surgery: Analysis of a Nationwide Institutional-Level Database With 94,277 Chinese Patients
por: Wu, Zhouqiao, et al.
Publicado: (2019) -
Staging laparoscopy for locally advanced gastric cancer in Chinese patients: a multicenter prospective registry study
por: Li, Ziyu, et al.
Publicado: (2018) -
Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer
por: Ye, Zaisheng, et al.
Publicado: (2021) -
POF (paclitaxel/oxaliplatin/5-fluorouracil/leucovorin) vs. SOX/CAPOX/FOLFOX as a postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer: Study protocol for a randomized controlled trial, FNF-014 trial
por: Su, Liyu, et al.
Publicado: (2022)